Palantir Stock vs. Nvidia Stock: Billionaire Ken Griffin Buys One and Sells the Other

Date:

Shares of Palantir Technologies (NYSE: PLTR) and Nvidia (NASDAQ: NVDA) have skyrocketed 223% and 194%, respectively, this year, as of Nov. 6 amid strong demand for artificial intelligence (AI). That makes them the second-best and third-best performing members of the S&P 500 behind electric utility Vistra.

Interestingly, Ken Griffin’s Citadel, the most profitable hedge fund in history as measured by net gains since inception, has been buying one stock and selling the other aggressively.

Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free »

  • Griffin purchased 4.6 million shares of Palantir through the first half of 2024, increasing his stake by 452%.

  • Griffin sold 33.9 million shares of Nvidia through the first half of 2024, slashing his stake by 93%.

Palantir and Nvidia are both well-positioned to benefit as the artificial intelligence boom builds momentum, but investors need to consider valuation in both cases. Here are the important details.

Palantir specializes in data analytics software. Its primary products, Foundry and Gotham, let businesses integrate data, develop machine learning (ML) models, and interact with those digital assets through prebuilt and custom analytical tools that improve decision-making. Its Artificial Intelligence Platform (AIP) enhances Foundry and Gotham by adding support for large language models and generative artificial intelligence.

In August, Forrest Research recognized Palantir as a leader in AI/ML platforms. AIP ranked above every other product on the market for its current capabilities, though Alphabet‘s Google received the highest score for its growth strategy. Principle analyst Mike Gualtieri commented, “Palantir is quietly becoming one of the largest players in this market.”

Palantir reported encouraging financial results in the third quarter. Its customer count climbed 39% to 629, and the average existing customer spent 18% more. In turn, revenue jumped 30% to $726 million, marking the fifth consecutive sequential acceleration, and non-GAAP earnings increased 43% to $0.10 per diluted share. But Palantir has a serious problem with its exorbitant price tag.

Among the 22 analysts who follow Palantir, just 27% rate the stock a buy. Wall Street estimates its adjusted earnings will increase by 29% over the next 12 months. That consensus makes the current valuation of 157 times adjusted earnings look absurd.

Rishi Jaluria at RBC Capital recently called it “unsustainable,” and I’m inclined to agree. Prospective investors should avoid this stock, and current shareholders should think about selling a few shares, even though Ken Griffin’s Citadel was a buyer throughout the first half of the year.

Share post:

Popular

More like this
Related